Cabaletta Bio

Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune diseases.

Medical Alert
Biotech

Patient suffers side effect in Cabaletta CAR-T trial

Analysts appeared unfazed by the news that a patient treated with Cabaletta Bio’s autoimmune CAR-T suffered a toxicity complication.
James Waldron Apr 2, 2025 6:55am
race car photo finish speed fast

Cabaletta's CAR-T shows 'robust benefit' in autoimmune patients

Feb 19, 2025 11:10am